Micro RNAs (miRNAs) are small regulatory molecules of increasing biologists' interest. miRNAs, unlikely mRNA, do not encode proteins. It is a class of small double stranded RNA molecules that via their seed sequence interact with mRNA and inhibit its expression. It has been estimated that 30% of human gene expression is regulated by miRNAs. One miRNA usually targets several mRNAs and one mRNA can be regulated by several miRNAs. miRNA biogenesis is realized by key enzymes, Drosha and Dicer. miRNA/mRNA interaction depends on binding to RNA-induced silencing complex. Today, complete commercially available methodical proposals for miRNA investigation are available. Th ere are techniques allowing the identifi cation of new miRNAs and new miRNA targets, validation of predicted targets, measurement of miRNAs and their precursor levels, and validation of physiological role of miRNAs under in vitro and in vivo conditions. miRNAs have been shown to infl uence gene expression in several endocrine glands, including pancreas, ovary, testes, hypothalamus, and pituitary.
Why is everyone incredibly crazy about miRNA?
Based on the recent knowledge, regarding the miRNAs structure and their interactions with mRNA, it has been estimated that 30% of human genes are modulated/regulated by miRNAs (Lewis et al. 2005) .
Scientifi c interest in miRNA exponentially grew since the beginning of the second millennium. Recent scientometric search have revealed that there are nearly 5000 papers about miRNAs published in 2014, most of them (1426) have been published in PloS One. Th e research was mostly conducted in the U.S.A., followed by China and Germany. Th e research topics are mostly focused on the biochemistry or medicine (search performed in January 15, 2016 by Scopus, key word: miRNA). Th e cross search "miRNA and hormone" issued 2000 papers.
Database miRBase at the beginning of the year 2016 registered 1881 precursors and 2588 mature miRNAs in Homo sapiens. According to the miRTarBase database (http://mirtarbase.mbc.nctu.edu. tw/php/search.php?opt=species&org=hsa), there are 65535 evidences for interaction of miRNAs with mRNA. Th e number of interactions is much higher in comparison with the number of miRNAs since miRNAs usually interact with several target genes. Th ere is a strong experimental evidence for miRNA-target interaction in 5858 cases. In these cases, the evidence was provided by combination of immunoprecipitation, luciferase reporter assay, real time PCR, and Western blot.
Th e most frequently reported miRNA is hsa-miR-155-5p with 228 reported interactions. Many interactions have independently been reported several times; e.g., interaction of hsa-miR-155-5p with CCAAT/enhancer binding protein beta has been reported eight times. Exclusion of all parallel proofs has revealed 154 interactions of hsa-miR-155-5p with certain genes (CCND1, MYC, MYB, ETS1, WEE1, RUNX2, TP53INP1, FOXO3, SOCS1, SMAD1 etc.).
Th e second most extensively studied miRNA is hsa-miR-21-5p with 213 interactions. Th ere have independently been reported 40 interactions of hsamiR-21-5p with phosphatase and tensin homolog (PTEN) and 36 interactions with programmed cell death 4 (PDCD4). Exclusion of all parallel proofs have revealed interactions of hsa-miR-21-5p with 86 genes (PTEN, BCL2, VEGFA, PDCD4, EGFR, E2F1, SP1, TGFBR2, RECK, ERBB2 etc.).
Th e most frequently reported gene is PTEN with 125 reported interactions with some miRNAs. Interaction of PTEN with hsa-miR-21-5p is the most frequently reported one. Th ere have occurred 41 interactions of PTEN with miRNAs aft er exclusion of repetitions (hsa-miR-21-5p, hsa-miR-29b-3p, hsamiR-221-3p, hsa-miR-17-5p, hsa-miR-29a-3p, hsamiR-200a-3p, hsa-miR-26a-5p, hsa-miR-222-3p, hsamiR-20a-5p, hsa-miR-141-3p etc.) . Th e second most frequently reported gene is B-cell CLL/lymphoma 2 (BCL2) with 95 interactions, regulated by 41 miRNAs (aft er exclusion of parallel proofs).
Recent overview has revealed that the processes, involved in cell cycle regulation and deregulation, are most oft en studied in relation to miRNA. Although, there exists an extensive in silico research and free online tools for performing it, no suffi cient attention has been given to growing miRNAs fi eld in other areas that require more complex (whole organ or organismal) evidence to prove their impact on a physiological function. Th is can be caused by the fact that miRNAs may target from several to many mRNAs. Moreover, aft er-interactions can infl uence the response to miRNAs administration in complex multicellular organisms.
Th e aim of this review is to show ways how to study and validate the miRNA functions and to provide a survey of existing knowledge about known roles of miRNAs in endocrinology.
What are miRNAs and where are they coming from?
miRNAs are small (17-25 nucleotides), noncoding, single stranded (ssRNA) types of RNA that belong to a large collection of small non-coding regulatory RNAs. Th ey have been found in various organisms, including plants, unicellular eukaryotes, and mammals, including humans. miRNAs possess a capacity to post-transcriptionally aff ect the biological activity of mRNA.
Besides miRNAs, there are several other groups of non-coding RNAs (ncRNAs) ( Table 1) . Th e number of RNAs within existing classes is still increasing and newly discovered classes of RNAs are still emerging. Small interfering RNA (siRNA) is involved in the regulation of mRNAs and is capable of cleavage of RNAs, derived from viruses and retroelements. Unlikely miRNAs, siRNAs have high sequence complementarity to their target mRNAs (Filipowicz 2005) . Other type of non-coding RNA is a small nuclear RNA (snRNA) that is involved in a splicing of small nucleolar RNA (snoRNA), performing ribosomal rRNA modifi cation and its processing in the nucleolus (Matera et al. 2007) . Table 1 provides a short overview of ncRNAs identifi ed in mammals (miRNAs identifi ed in other classes not present in humans are not listed) with explanation of their names and brief description of their functions (Holley and Topkara 2011; Dogini et al. 2014) .
Th e fi rstly discovered miRNA was lin-4 found in the Caenorhabditis elegans (C. elegans) in 1993 by the team of Victor Ambros during the study of larval development (Lee et al. 1993) . miRNA let-7 was later discovered by another research group also in the C. elegans studies. It has been reported that both miRNAs participate in the negative regulation of translation (Reinhart et al. 2000 ). An intensive research centered to miRNAs has begun with the paper of Fire et al. (1998) reporting about powerful eff ect of doublestranded RNA on the gene expression.
Nomenclature of miRNAs
Nomenclature of miRNAs obeys strict rules that signifi cantly contribute to the progress in this fi eld. Each miRNA has assigned sequential numerical identifi er and usually use three or four letter prefi xes to designate the species (e.g. hsa -Homo sapiens, mmu -Mus musculus, dme -Drosophila melanogaster). Mature miRNA sequences are designated with "miR", while precursor forms have assigned "mir". Paralogue mature sequences, with diff erences only in one-two positions, are given lettered suffi xes (e.g. mmu-miR-10a and mmu-miR-10b in mouse) or number suffi xes in case of diff erences in precursor forms that give rise to identical mature miRNAs (dmemir-281-1 and dme-mir-281-2 in D. melanogaster). Two mature strands that originate in the opposite arms of one precursor are named aft er 3´ and 5´end of precursor miRNA sequence e.g. miR-21-5p (5´ end) and miR-21-3p (3´end). In some cases, asterisk can indicate the passenger strand of mature miRNA. Th e numbering of miRNA genes is sequential and usually refl ects chronology of miRNA identifi cation. let-7 and lin-4 are rare exceptions, accepted because of historical reasons (Griffi ths-Jones et al. 2006) .
miRNA transcription
Biogenesis of miRNAs ( Figure 1 ) starts with their transcription, which is an important step in the regulation of their expression. Some of the miRNA genes are transcribed from their own promoters from regions between transcription units (intergenic miRNA). Approximately 50% of miRNAs are located in the intronic part of known protein coding genes (intronic miRNA) (Rodriguez et al. 2004; Kim 2005) . Subsequent analysis of miRNA biogenesis has shown that approximately 50% of miRNAs are clustered in polycistronic regions that involve usually two or three genes per cluster in human (Lee et al. 2002; He et al. 2005) .
Although, the majority of small non-coding RNAs, such as tRNA or snRNA, are transcribed by polymerase III, there is evidence indicating that majority of the mature miRNAs are originally polymerase II products. Th e primary transcript (pri-miRNA) is much longer (over 1kb) than conserved stem loops sequence of pre-miRNA and contains a 5´-7-methyl guanosine cap and poly(A) tail (Lee et al. 2002) . Th ese structures are typical for transcripts that are produced by the RNA polymerase II. Lee et al. (2004a) have provided the fi rst experimental evidence that a single polycistronic miRNA gene, containing miR- (Monteys et al. 2010) . Th us, both polymerases participate on transcription of miRNA through specifi c promoters or regions that are highly similar to the regions of protein-coding genes such as CpG island, TATA box, and TFIIB recognition region (Ozsolak et al. 2008; Corcoran et al. 2009 ).
miRNA processing by microprocessor complex and Dicer
Th e maturation of miRNAs continues in the nucleus by cleaving pri-miRNA into approximately 70nt hairpin structure, called precursor miRNA (premiRNA). Microprocessor complex, which consists of RNase III enzyme (Drosha) and DiGeorge syndrome critical region gene 8 (DGCR8), known as Pasha in D. melanogaster and C. elegans and double-stranded RNA-binding domain (dsRBD) protein, takes action in this process (Lee et al. 2003; Denli et al. 2004; Landthaler et al. 2004 ). Drosha cleaves RNA by binding to the hairpin producing 2nt overhang typical for 3´ end of pre-miRNA. Both, Drosha and DGCR8, have to be active during the processing of pri-miRNA. Typical pri-miRNA consists of hairpin structure and stem that is about 33nt long. A region important for processing by Drosha is a stem and two fl anking ssRNAs. Th ese segments are recognized by DGCR8 that navigates Drosha to cut stem several nts away from the stem junction at the base of the hairpin, which results in producing pre-miRNA (Han et al. 2006) .
In 2007, several experimental teams discovered a type of miRNA that is able to skip Drosha cleavage, called Mirtrons. Th ese intron-mediated miRNAs are produced by splicing from their host transcript. Th ey form hairpin structures, resembling the classic premiRNA just by splicing machinery. It enables further processing in the cytoplasm by Dicer bypassing the Drosha activity. Mirtrons are present in various species, including mammals (Berezikov et al. 2007; Okamura et al. 2007 ).
Aft er processing by microprocessor complex in the nucleus, pre-miRNA is transported into the cytoplasm by binding to the Exportin 5 (Yi et al. 2003) . Exportin 5 is a member of karyopherin family of nucleocytoplasmic transport factors, fi rstly identifi ed to mediate the nuclear export of adenovirus VA1. However, it can also function as a secondary receptor for tRNA nuclear export. Th e action of this transporter is Figure 1 . miRNA biogenesis pathway. Aft er transcription by polymerase II/III, a primary transcript (pri-miRNA) is processed in the nucleus by RNase III (Drosha) and DiGeorge critical region gene 8 (DGCR8) into precursor miRNA (premiRNA). Transporting pre-miRNA from the nucleus is mediated by Exportin 5 (Expo5). In the cytoplasm, pre-miRNA is cleaved by RNase III called Dicer together with its catalytic partner TAR-binding protein (TRBP) and forms mature miR-NA duplex. miRNA duplex is subsequently incorporated to the RISC (RNA-induced silencing complex) that consists of one member of Argonaute family proteins (AGO), TRBP and Dicer. Aft er strand selection, leading (or guide) strand of miRNA duplex exerts translation repression or cleavage of mRNA.
based on the presence of GTP-bound form of the Ran GTPase in the nucleus. Cytosolic factor-facilitated hydrolysis of Ran-GTP to Ran-GDP induces release of cargo, in this case pre-miRNA, into the cytoplasm (Calado et al. 2002; Yi et al. 2003) .
Once the pre-miRNA is transported into the cytoplasm, it is cleaved by the second RNase III called Dicer (Bernstein et al. 2001) . Th is enzyme is essential for processing pre-miRNA into bioactive moleculemature miRNA. In vertebrates and C. elegans, there is present only one type of Dicer, while D. melanogaster genome contains two forms of this RNase III enzyme, from which Dicer-1 is involved in miRNA biogenesis, while Dicer-2 participates in another form of RNA interference (Lee et al. 2004b) . Dicer homologues are typical by several domains -two catalytic RNase III domains, PAZ domain, dsRNA binding domain, and ATPase/RNA helicase domain (Kim 2005; Filipowicz 2005) . Dicer is capable of cleavage activity itself, without any cofactors. Anyway, association of this enzyme and protein from Argonaute family has probably additional functions in providing miRNA stability and eff ector complex formation and action (Kim 2005) . Argonaute proteins are important players in the gene silencing. Th ey are involved not only in miRNA or siRNA functions, but the subfamily of Piwi Ago proteins also aff ect piRNA mediating translation repression (Hock and Meister 2008) .
Interaction between Dicer and pre-miRNA is provided by helicase domain. Protein TRBP (trans-activation response RNA-binding protein) that contains double stranded RNA binding domain has an important role in the enhancing and modulating of Dicer activities (Chendrimada et al. 2005) .
Th e Dicer product is a double stranded miRNA helix with approximately 2 nt 3´overhang at both ends. Dicer has a molecular ruler and is able to cut dsRNA in a specifi c distance from the beginning of the helix (MacRae et al. 2006) .
RISC assembly and strand selection
Aft er cleaving by Dicer, it is necessary to unwind the double stranded helix of miRNA/miRNA* and separate the guide strand with biological function from the passenger strand. Th is process is called strand selection and it determines which strand will form active complex with RISC (RNA-induced silencing complex) and which one will be degraded (Schwarz et al. 2003) .
Th e core of RISC is composed of one of four human Argonaute proteins (Ago1-Ago4), associated with several cofactors like Dicer, Hsp90, and double stranded RNA-binding proteins: TRBP and/or PACT (protein activator of dsRNA-activated protein kinase) (Pare et al. 2009; Noland and Doudna 2013) . Th ese cofactors are important for loading of the miRNA duplex. Loading of the miRNA duplex is a process of activation RISC with assistance of Hsp90 mediating conformational changes of Ago, which allows miR-NA duplex to enter the RISC (Pare et al. 2009; Gu et al. 2011) . Maturation of RISC begins with unwinding the duplex. In the case of siRNAs, which are typical for almost complete base-paired stem, the unwinding process is characterized by immediate destroying the passenger strand; but for miRNA duplexes, cleavage step is bypassed because of the multiple mismatches for miRNA/miRNA*, which probably inhibit the act of cleaving (Matranga et al. 2005) . Th is bypass mechanism in processing the miRNAs is executed by all known mammalian Ago proteins.
Presumably, a duplex functional asymmetry is crucial in determination of leading or guide (executive) strand and passenger strand. Th ermodynamic stability and weaker base pairing relative to the other strand are supposed to be the key regulating factors. Strand with weaker interaction at the 5´ end will become more frequently the leading strand. It has been suggested that the weaker interaction enables the Ndomain of Ago to initiate more easily the unwinding process of duplex (Schwarz et al. 2003; Krol et al. 2004) . Moreover, the guide strand usually starts with uracil base at the 5´ end and is typical for excess with purines (A/G) (Hu et al. 2009 ).
Aft er incorporation of duplex and strand selection, RISC complex mediates the miRNA induced silencing. Whole miRNA sequence shows only partial complementarity with its targets. RISC complex presents only part of it, the 2-8nt sequence called the seed sequence (with high complementarity to mRNA), and subsequently proceeds with down-regulation of gene expression that includes two processes: translation repression and/or mRNA cleavage. Aft er cleaving of mRNA, the miRNA is not destroyed and can interfere with another target (Hutvagner and Zamore 2002) .
Regulation of miRNA biogenesis
Although, there is growing evidence that miRNAs regulate up to 1/3 of gene expression, much less is known about the regulation of miRNA production.
Knockouts of Drosha, DGCR8, Dicer and Argonaute protein. Several knockouts of key enzymes, involved in biogenesis of miRNAs, have been generated that helped to understand some of miRNA functions in the organism. Th e DGCR8 protein (cofactor for Drosha), a component of microprocessor complex, has been found to be essential for the miRNA biogenesis. Knockout of dgcr8 gene in mouse embryos and embryonic cells cause impaired diff erentiation and development (Wang et al. 2007 ).
Drosha activity is essential for the survival in mice (Fukuda et al. 2007 ). Conditional Drosha and Dicer knockouts mice line, with inactivated Drosha and Dicer in spermatogenic cells, were infertile. Separate disruption of Drosha appeared to have more severe eff ect on spermatogenesis and fertility compared to Dicer inactivation in this model (Wu et al. 2012) .
Homozygote mutation of dicer gene is lethal. Homozygous knockout embryos die aft er 12 th day of gestation, showing strongly impaired angiogenesis . Specifi c loss of Dicer in various organs and cell lines has confi rmed a signifi cant role of Dicer in normal development or physiological functions, e.g. morphogenesis of limp, myocardium, retina, thyroid, hippocampus, cortex, and many others (Harfe et al. 2005; Murchison et al. 2007; da Costa Martins et al. 2008; Davis et al. 2008a; Georgi and Reh 2010; Frezzetti et al. 2011 ). While Dicer is necessary for oocyte maturation, conditional knockout of DGCR8 that is specifi cally required for miRNAs processing, did not aff ect the production of oocytes (Suh et al. 2010) . Eff ects of miRNA-reduced synthesis were observed also in Drosha and Dicer defi cient endothelial cells. Silencing of Dicer expression in the endothelial cells caused decreased migration of cells and angiogenesis. Th e eff ect of Drosha silencing in the endothelial cells was less severe in vitro and totally disappeared in vivo (Kuehbacher et al. 2007) . It is important to note that Dicer is also involved in the biogenesis of siRNA, so physiological impairment in Dicer-defi cient cells or organism may be due to suppressed production of other interfering RNAs.
Although family of Argonaute proteins includes key enzymes involved in miRNA biogenesis and machinery, only knockout of one of its members -Ago2 has been found to be lethal early in the embryonic development (Morita et al. 2007 ). Ago2 also plays a crucial role in the proper slicing of the blood specifi c miRNAs, involved in erythropoiesis (Cheloufi et al. 2010) . Th e specifi c loss of both Ago1 and Ago2 in the skin leads to a decreased expression of miRNAs and severe defects in the skin morphogenesis ).
Regulation of miRNA transcription and processing. Core transcriptional enzymes of miRNA primary transcripts are widely expressed and they are not likely to be limiting regulatory step. Th ere have been identifi ed many miRNAs transcription factors, e.g. p53, c-myc, MEF2, and REST. Tumor suppressor p53 is known to activate miR-34a-c cluster, involved in regulation of cell cycle and carcinogenesis (He et al. 2007; Raver-Shapira et al. 2007 ). c-myc is other well established oncogenic protein that has been shown to stimulate or repress the expression of various miRNAs, e.g. c-myc activates miR-17-92 cluster transcription by binding to E-boxes. On the other hand, c-myc inhibits expression of several other miRNAs (e.g. miR-22, miR-26a, miR-29c) (Chang et al. 2008) . Th e expression of miR-7 in the Drosophila eye is activated during photoreceptor diff erentiation owing to suppressed transcriptional factor Yan that represses miR-7 transcription in non-diff erentiated cells. miR-7 negatively regulates expression of Yan in diff erentiated cells. In this way, miR-7 and Yan form double-negative transcriptional feedback loop (Li and Carthew 2005) .
While regulation of miRNA transcription determines the level of precursor's forms, it is important to realize that precursor levels do not always match with the levels of mature miRNAs (Zhang and Zeng 2010) . Some post-transcriptional regulatory mechanisms became known owing to studies aimed on changes in miRNA expression during the development. miRNA expression profi le is changing during the ontogeny. Only few miRNAs are expressed in early embryos. Th e number of expressed miRNAs continuously increases and culminates during the adulthood. From the ratio of primary transcript and mature forms of some miRNAs during the development, it has been suggested that regulation can occur in the Drosha regulatory step (Th omson et al. 2006 ). According to a correlative study, comparing the expression of precursor and mature miRNA, there are following categories:
1. precursor and mature miRNAs correlates, e.g. miR-100, miR-155, miR-125a; 2. correlation between precursor and mature miRNA is limited to some tissues or cell lines, e.g. miR-9, miR-1 and miR-216; 3. expression of mature miRNA is running in certain cells lines/tissues, while precursor is expressed in all or most tissue cells; 4. both mature as well as precursor miRNA are not expressed . In vitro studies have confi rmed diff erences between precursor and mature miRNAs. Lipopolysaccharide induced pre-miR-155 expression in human monocytes, achieved maximal levels 2 h aft er admin-istration, while expression of mature miR-155 peaked 9 h later. Concentration of mature miRNA was higher compared to pre-miRNA that can be explained by diff erences in their turnover. It has been suggested that pre-miRNAs are degraded earlier than miRNAs. However, the way in which levels of pre-miRNAs and miRNAs are regulated can diff er, depending on tissue and particular miRNA .
In some cases, miRNAs are present as precursors, but the mature forms are missing. It has been reported that Drosha cleaves miRNAs with diff erent effi ciency under in vitro conditions and this can be positively correlated with levels of mature miRNAs in vivo. Protein DGCR8 has been shown to have major stabilizing eff ect on Drosha via interaction with its middle domain and Drosha can regulate, vice versa, the activity of DGCR8. Th erefore, a balance between activities of these two proteins to keep miRNAs cropping fl uent has to be achieved. Effi ciency of Drosha cleavage of particular pri-miRNA is indicated by several features, such as fl exible or large terminal loop region and fl anking single stranded RNA regions (Feng et al. 2011 ). In addition, other specifi c and non-specifi c control mechanisms of Drosha activity have been described. Th e fi rst, well-known miRNA specifi c regulator is RNA binding protein Lin-28 and his homologue Lin-28B that down-regulates maturation of let-7 by inhibiting its cleavage step by Drosha. Lin28 induces uridylation of precursor let-7 that cannot be cleaved by Drosha and is degraded. It has also been shown that translation of Lin-28 is inhibited by let-7 that closes double negative feedback loop (Heo at al. 2008; Newman et al. 2008) . Tumor suppressor BRCA1 has been found to enhance the activity of Drosha by direct interaction (Kawai and Amano 2012) . Group of proteins SMAD through interactions with BMP/TGF-β stimulate Drosha processing of miR-21 in vascular smooth muscle cells (Davis et al. 2008b) . It has been shown that some mature miRNAs (e.g. miR-709) are capable negatively aff ect Drosha processing of other miRNA cluster (miR-15a/16-1). Th ese fi ndings suggest that miRNAs can also contribute, except of target regulation in the cytoplasm, to the regulation of biogenesis, occurring in the nucleus (Tang et al. 2012) .
Regulation of miRNA processing occurs also at the level of Dicer activity. Dicer accumulation in the cytoplasm is dependent on the Dicer partner TRBP and TRBP knockout causes Dicer destabilization and premiRNA processing impairment (Melo et al. 2009 ). It has previously been described that Lin-28B blocked Dicer processing of let-7 (Heo et al. 2008) . let-7 and miR-107 can aff ect Dicer and potentially infl uence the processing of its own precursors forms (Forman et al. 2008) .
Once miRNA and the functional RISC complex are generated, miRNA appears to be surprisingly stable. Functional RISC complex can regenerate and catalyze cleaving of another target. Th erefore, it is not limiting factor for miRNA-mediated regulation . Since association of miRNA with Ago have protective eff ects against destruction by nucleases, Ago proteins can increase the abundance of mature miRNAs (Diederichs and Haber 2007; Zhang et al. 2012) . miRNA recycling is believed to be regulated by the target posttranscriptional modifi cation of miR-NA and decrease of its stability (Baccarini et al. 2011) . It has been suggested that complementarity of miR-NA and their targets can trigger miRNA degradation. miRNA can be found in P-bodies. It is still not known whether this is a way to inactivate miRNAs or to store them (or both) (Parker and Sheth 2007) .
Circadian regulation. Based on evidence from several species, including A. thaliana, D. melanogaster, and mouse models, a rhythmic control of miRNA expression is conserved from plants to mammals.
Th e circadian system regulates at least two miRNAs in D. melanogaster (miR-263a and miR-263b) with a rhythmic pattern that was abolished in arrhythmic clock mutant cyc01 . A daily variation of miR-16 and miR-181 expression has been observed in human leukocytes with the maximum in the middle of the light phase. A rhythm of miR-96 and miR-182 expression in mouse retina and a weak rhythm of miR-16, miR-20a, miR-141 show maximum in the light phase in rat´s intestine (Xu et al. 2007; Balakrishnan et al. 2010; Figueredo et al. 2015) .
Beside the evidence of the existence of circadian regulation of specifi c miRNAs, there exists also knowledge about the circadian variation of core enzymes that control miRNA biogenesis. According to Yan et al. (2013) , Dicer shows a diurnal pattern of expression in the suprachiasmatic nuclei (SCN), retina, liver, and bone marrow that disappeared or weakened during aging or diabetes in mammals.
Evidence supporting the reciprocal regulatory relationship between miRNA and circadian system is growing. miR-219 and miR-132 show a distinct daily rhythm in mice SCN with higher expression during the light phase of light:dark cycle. Expression of miR-132 has been proved to be light inducible via MAPK/ CREB dependent mechanism. Administration of miR-132 antagomirs showed that miR-132 negatively modulated the light entrainment. miR-219 is controlled via circadian oscillator by CLOCK/BMAL heterodimer binding to E-box found in its promoter region. Down-regulation of miR-219 lengthens the circadian period of free running activity in mice (Cheng et al. 2007 ). Th ese authors have identifi ed miR-219 and miR-132 as modulators of CLOCK/ BMAL1 dependent per1 transcription.
miR-494 and miR-152 have been found to be rhythmic in bimodal fashion in mouse serum and miR-494 post-transcriptionally repressed bmal1 expression under in vitro conditions (Shende et al. 2011) . All three period genes are validated target genes for cluster miR-192/194 (Nagel et al. 2009 ). Another study has revealed post-transcriptional regulation of cryptochrome1 by miR-185. Th e protein level of CRY closely corresponds with antiphase of cytosolic level miR-185 . Th ese fi ndings suggest that miRNAs may play a role in the regulation of the expression of clock genes and infl uence the circadian system (Shende et al. 2011 ).
How to identify miRNA target?
Since number of newly identifi ed miRNAs is constantly growing, the number of their possible targets is increasing, as well. Crucial importance is to recognize the biologically relevant interactions. So far, there are no strict rules to determine what kind of evidence is suffi cient. In the present review, we provide a few examples of recently used validations of miRNA/mRNA interactions.
Computational prediction of miRNA targets
Research focused on miRNA is recently supported by several useful databases. One of the most accessed and constantly upgraded is the database of miRNA sequences miRBase available at web page http://www. mirbase.org/ (Griffi ths- Jones et al. 2006) .
Hundreds of miRNA have been described with use of high throughput sequencing. Our capacity to understand their functions strongly depends on our potential to discover targets of particular miRNA. Mammalian targets can be predicted by searching for conserved 7nt matches in the 3´UTRs regions complementary to miRNA so-called "seed" sequence. Seed sequence is a region between nucleotides 2 and 8 at the 5´ end of the miRNA with high complementary sequence to mRNA. Complementarity of seed sequence in the central and 3´ end is frequently incomplete (Lewis et al. 2005) . mRNA motifs that match miRNA should be more evolutionary conserved compared to motifs with the same abundance in the same UTR that do not match miRNA sequence. Ratio of positive identifi cation of miRNA/mRNA target is than 3.5:1. Profi ling mRNA and miRNA studies have indicated that mRNA targeting can frequently occur on non-conserved sites, as well. Th erefore, this approach is recently used as well, although this opinion has opponents. Except the above mentioned features, there are some additional rules to look for miRNA targets: 1) distance at least 15nt from the stop codon within 3´UTR region; 2) avoiding of positioning in the center of long UTRs; 3) take into account site accessibility e.g. AU-rich nucleotide sequence, near the suggested site; 4) presence of sites for coexpressed miRNAs in neighborhood; 5) to avoid complex RNA secondary structures and 6) free energy (ΔG) of the 70 nucleotides around 5´ and 3´ end of predicted miRNA binding site (Kuhn et al. 2008; Bartel et al. 2009 ). miRNA interfering sites can be estimated with help of several freely accessible databases. Th e rules mentioned above are preferentially useful for picking up an experimental target for further validation.
Databases for search of mammalian miRNA interferences (adapted from Bartel et al. 2009 
Identifi cation of miRNA/mRNA interactions
To identify miRNA/mRNA interactions is possible by using antibodies against proteins associated with miRNA/mRNA complex, e.g. proteins creating RISC. miRNA and particular 3´UTR region coimmunoprecipitate with antibody targeted protein.
Technique based on the ribonucleotide immunoprecipitation, as described by Hassan et al. (2010) , identifi es miRNA target from polysomal extract aft er ribonucleotide immunoprecipitation. Polysomal ex-tract was prepared from preosteoblast cell line. Immunoprecipitation with Ago2 or GW182 antibody coupled to agarose beads was followed by release of ribonucleotide complex from beads and Trizol extraction of RNA. cDNA was synthesized from isolated RNA by using miRNA seed specifi c primer. PCR amplifi cation was performed with primers designed to match upstream 3´UTR region of computationally predicted mRNAs to be targets of miRNA (used for design of reverse transcription primer).
Interaction of miRNA/mRNA can also be detected by using the biotinylated miRNA mimics. Aft er transfection, modifi ed miRNA cells are harvested 24 h later and complexes of biotinylated RISC and mRNA are pulled down with streptavidin-coated magnetic beads. Samples infl uenced by miRNA can be compared to total mRNA isolated from control cells by array (Lal et al. 2011) .
Another approach describes a cell system using generation of cDNA library, derived from oligo dT primed total RNA, isolated from tissue of interest. p3TKzeo plasmid encoding a thymidine kinasezeocin fusion protein is used to perform dual-selection of sells. Th e 3´UTR-enchriched plasmid library is transfected into cells that do not express miRNA of interest. Cells expressing 3´UTR sequence can be selected by zeomycin. Zeomycin resistant cells are than transfected by miRNA. If miRNA silences 3´UTR region, thymidine kinase expression should be inhibited and cells with miRNA/mRNA interaction can be selected by ganciclovir. Cells producing thymidine kinase in the presence of ganciclovir will not survive. Ganciclovir selected clones can be aft er amplifi cation sequenced. In this way, it is possible to reveal new miRNA targets without any information about mRNA sequence or computational prediction (Gaken et al. 2012 ).
Measurement of miRNA interference end product
Th ere are many ways how to measure the product of the hypothesized miRNA target. It is possible to measure mRNA as well as protein product of mRNA. Coexpression is an obvious prerequisite of miRNA/ mRNA interaction, but it is important to remind that miRNAs usually target several mRNAs and fi nal effect on transcriptome can be mediated via several regulatory steps. Th erefore, this validation requires additional tests.
Measurement of miRNA expression is described in detail in the next paragraph. mRNA is most frequently measured by real time PCR, as designed by user or purchased assays. Several commercial tools are available to profi le mRNA by real-time PCR expression using 96 or 384 platform, allowing monitoring many possible miRNA targets simultaneously (Qiagen, Th ermo Fisher).
To visualize the expression of miRNA at the localization, when target mRNA is abundant, is possible by in situ hybridization. Th is technique allows studying the intracellular distribution of miRNA within physiological concentrations. Digoxigenin-labeled antisense miRNA probes are commercially available. Probe bound to the target is visualized by using digoxigenin antibody conjugated to alkaline phosphatase. It is also possible to perform in situ reverse transcription and PCR to amplify signal (Kuhn at el. 2008) .
Th e Western blotting is the most usual way to measure the eff ect of miRNA on the concentration of the mRNA protein product. ELISA (enzyme-linked immunosorbent assay) is an alternative to Western analysis.
Evaluation of miRNAs eff ects on physiological function
Cell cultures are most oft en used to prove physiological eff ect of miRNA on intracellular process. To validate the predicted miRNA/mRNA interaction, reporter systems are frequently utilized. 3´UTR of studied mRNA is cloned downstream of the luciferase or green fl uorescent protein open reading frame in the appropriate reporter plasmid. Th e complete sequence of 3´UTR region should be tested to assure that other sequences possibly infl uencing binding of miRNA are not present in the plasmid.
Th e recombinant plasmid and candidate miRNA are transiently transfected into the cells that do not produce studied RNAs. Aft er transfection of miR-NA into the cell (e.g. with Lipofectamine or similar product), a Luciferase reporter construct, containing desired 3´UTR region with miRNA binding site, can be used to monitor the activity of the regulated gene. Signal produced by reporter gene is measured 24-48 h aft er the transfection. Th ere is commercially available collection of 12 000 human 3´UTR luciferase reporter clones that are transfection-ready (SwithGear Genomics).
Function can be further validated by overexpression of miRNA or miRNA mimics. miRNA mimics are commercially available chemically modifi ed double-stranded RNAs that mimic the function of endogenous miRNAs. Eff ect of miRNA can also be tested by introducing of mutation into seed sequence miRNA or 3´UTR region of target mRNA (Kuhn et al. 2008; Vasudevan 2012) . Lately, sponge mRNAs are being used to inhibit specifi cally the activity of whole family of miRNAs with the same seed sequence. Sponge mRNAs contain multiple target sites complementary to miRNA of interest and by binding to miRNAs inhibit their function (Ebert and Sharp 2010 ). Antagomirs represent another class of newly developed tools for modulating miRNA function. Antagomirs are chemically modifi ed single-stranded RNA analogues complementary to miRNA that cause silencing.
Interaction of reporter plasmid containing 3´UTR region of gene of interest and miRNA are analyzed in supraphysiological concentrations. Th erefore, other techniques are usually used in combination with reporter system.
Changes in target mRNA should be accompanied by a change in some physiological function. Th e most frequently used techniques monitor cell proliferation, diff erentiation, cell death, cell migration, production of some metabolite, enzyme or signal molecule, etc.
Th e effi cient and easily incorporable way to validate the role of miRNA in the cell cycle regulation is the measurement of BrdU incorporation that can be aft er appropriate staining analyzed by microscopy or fl ow cytometry. Mitotic index can be determined by measurement of phosphorylated histone H3 and appropriate staining by the cytometry (Yang et al. 2015) .
Studies focused on the physiological processes affected by miRNA require a mammalian experimental model. A novel approach, based on strongly diff erent transcriptome of mRNA and miRNA of two mice strains (C57BL/6 and SPRET/Ei), has been used to validate the function of miRNA (Timmermans et al. 2015) . Plasmid containing tested miRNA was injected hydrodynamically into the tail vein. It has been previously reported that miRNA plasmid injection in this way causes its overexpression mainly in the liver with peak expression aft er 8 h (Liu et al. 1999 ). Based on the diff erences between C57BL/6 and SPRET/Ei transcriptomes candidate, miRNAs have been used to infl uence mRNA expression in the liver of SPRET/ Ei mice. Th is approach was successful.
Knockouts of miRNAs
Th e generally used approach of the physiological function validation is a gene knockout under in vivo conditions. Since position of miRNAs is usually known, it is possible to perform knockout of a particular miRNA.
Several miRNAs have been identifi ed that are essential for the development and their deletion may cause embryonic lethality. One of the fi rst indispensable miRNAs described were miR-1-1/miR-1-2 or cluster miR-17-92. Deletion of these miRNAs causes a prenatal death, mainly due to the cardiac and lung impaired development. Target knockout of endothelial specifi c miR-126 caused 50% lethality and surviving mice displayed defects in the angiogenesis and vascular integrity . Some miRNAs are present in mammals as duplicates or homologues, which in specifi c cases could be the reason for the functional redundancy. Functional redundancy has been shown in mice lacking either miR-133a-1 or miR-133a-2 that did not show pathology. However, double deletion of both miRNAs is connected with lethal heart defects and heart failure in one-half of the monitored cases .
Cluster miR-17-92 has been also found to be essential for lung and B-cell development. Mice with knockout of this cluster died soon aft er birth. However, mice lacking cluster miR-106a-363 or miR106b-25 were viable with no abnormalities. Triple deletion of miR-106a-363, miR-106b-25 and miR-17-92 caused even more severe eff ects compared to those observed in single miR-17-92 knockouts. Th is study suggests that interactions between above-mentioned clusters can infl uence physiological processes (Ventura et al. 2008) .
Other deletion study has revealed a role of miRNAs in the aorta morphology. It has been demonstrated that specifi c loss of miR-143 and miR-145 may induce morphological changes in the aorta. miR-143 and miR-145 have previously been confi rmed as down-regulated in human aortic aneurysms (Elia et al. 2009 ). In mice, deletion of pancreas specifi c miR-375 caused impaired glucose homeostasis, hyperglycemia, and increased gluconeogenesis. Th e mice exhibited elevated total pancreatic alpha-cell numbers and slightly decreased beta-cell mass (Poy et al. 2009 ). Cartilage specifi c miR-140 was also examined in the knockout experiments. Young mice with deletion of miR-140 showed only mild skeletal phenotype with short stature and low body weight. However, miR-140 knockout caused accelerated onset of age-related changes, such as proteoglycan loss and fi brillation of articular cartilage characteristic for osteoarthritis (Miyaki et al. 2010) .
What is the most suitable way to detect and evaluate miRNA?
Laboratories with good laboratory practice in RNase free work (e.g. https://www.qiagen.com/us/ resources/molecular-biology-methods/rna) can adapt methods required for miRNA studies quite easily. Th e use of miRNA requires generally the same laboratory conditions and equipment as for the work with RNA. Th ere is a substantial diff erence in the size between the mature miRNA and mRNA. Because of diff erences in molecular weight between miRNA and mRNA, isolation of small RNAs may slightly diff er from isolation of messenger or total RNA. However, reverse transcription requires specifi c modifi cations.
Sampling and isolation
miRNA analysis begins with a sampling. A gold standard in experimental research is that sample intended for RNA isolation is snap frozen in the liquid nitrogen immediately aft er tissue excision. Because of the growing trend to use miRNA in medicine, there is a strong eff ort to measure miRNA in samples taken from histological materials and biofl uids. miRNAs are highly stable in formalin-fi xed paraffi n-embedded tissues (Nelson et al. 2004) . Th ey were successfully isolated from formalin-fi xed and paraffi n-embedded tissues with higher success compared to mRNA (possibly because of shorter sequence). Circulating miRNAs are frequently analyzed in the plasma and serum, where their levels correlate well (Mitchell et al. 2008) . Endogenous miRNA has been reported to be surprisingly stable in plasma and serum . miRNA are transported in circulation bound to other molecules or packed in vesicles that protect them from degradation by high plasma RNase activity. It has been shown that measurement of miRNA in plasma is not infl uenced by 24 h lasting incubation at room temperature or eight freeze-thawing cycles. Artifi cially added naked miRNAs were degraded in plasma within 2 min (Mitchell et al. 2008 ). Since cells contain much more miRNA compared to plasma or serum, it is crucially important not to contaminate the biofl uid sample by miRNA from cells. EDTA is preferred before heparin when plasma will be used for analysis. Aliquots should be stored under -80 °C.
Several kits for miRNA isolation are commercially available (Burgos et al. 2013) . Most of the companies, providing chemistry for gene expression studies in their portfolio, implemented also chemistry for miRNA measurement (e.g. Qiagen, Th ermo Fisher, Roche and others). Most of these column-based systems employ phenol/guanidine-based lysis combined with binding of miRNA on silica-membrane or special glass fi bers and elution of miRNA into 30-100 μl of RNase-free water aft er several washing steps. Th is procedure usually involves also removing of DNA and proteins from samples as well as miRNA dissolving and possibility to concentrate sample, if it is needed. Column-based isolation may be especially good choice for isolation of circulating miRNAs, since it allows to scale up initial volume of sample with denaturing reagent up to 50 ml and to concentrate yield in early steps. Th us, the fi nal concentration of isolated miRNA can achieve the needed level. Th e lowest volume of fl uid sample for miRNA extraction is around 200 μl but the amount of miRNA extracted from this volume is not suffi cient for profi ling.
In spite of many advantages of this approach, the kits mentioned above are costly. Researchers routinely using TRI Reagent can easily adopt solution provided for miRNA isolation Tri-reagent alternative -RNAzol RT. Using of RNAzol RT is reliable and aff ordable option for experienced user. miRNAs are present also in standard Tri-reagent isolation but it is estimated that small RNAs make up less than 1% of total RNA and samples may not obtain concentration high enough to perform arrays although it can be suffi cient for standard real-time PCR. Columnbased technology for mRNA isolation usually did not recover small RNAs. Another advantage of isolation with Tri-reagent or RNA-reagent is that it does not interfere with any method possibly employed aft erwards. Yield of miRNA from tissues is usually suffi cient for measurement of concentration by spectrophotometer. In order to control the extraction step, a synthetic miRNAs from another species can be added into the homogenate (Mitchell et al. 2008 ).
Reverse transcription
Precursor miRNA. Since sequences of primary precursor miRNA and precursor miRNA are longer compared to the mature miRNA, their reverse transcription allows employing specifi c primer as well as random hexamers. Th e gene-specifi c primer utilization has been reported to be much more eff ective compared to reverse transcription with random hexamer. Gene specifi c primers have been reported to be used in cocktail. Th is approach requires information about sequence of miRNA precursor and only known sequences are obtained by this way. On the other hand, it is a way to enrich specifi c miRNA in case of nonspecifi c signal in PCR or very rare miRNA (Schmittgen et al. 2004) . Today, the interest is more focused on the mature miRNA.
Mature miRNA. Since sequences of mature miRNAs are very short, an elongation of isolated miRNAs proceeds reverse transcription, elongation is performed on 3´ end of sequence and there are several ways how to realize it.
Sequence specifi c reverse transcription uses linear or stem loop primer complementary to 3´ end of miRNA with a tag used later in PCR. Th ere are diff erences between reverse transcription with linear and stem loop reverse primer. Linear primers are easier to design but transcribe mature as well as precursor miRNA. Stem loop primers show reduced binding to precursor miRNAs. A target-specifi c stem-loop reverse transcription uses and adapter to extend 3´ end of miRNA (Chen et al. 2005) . A stem loop primer with a short sequence complementarity to 3´ end is hybridized to miRNA fi rst and then reverse transcription is performed (this solution is commercially provided by Th ermo Fisher). In this case, reverse transcription is target specifi c, but if properly designed, it can be optimized for multiplex reaction.
Th e most frequently used nonspecifi c reverse transcription applies adenylation of 3´ end (Shi and Chiang 2005) . Th is may be done by using a poly(A) polymerase. miRNAs are then reverse transcribed with use of oligo-dT primers with 3´ degenerate anchor and a universal tag sequence on 5´ end that is later used to amplify cDNA synthesized from miR-NA in the real time PCR (this solution is commercially provided by Qiagen). Th is vendor off ers also possibility to synthesize all small non-coding RNAs and mRNA, using existing poly(A) tail (mRNA) or poly(A) tail addition with slightly diff erent set up. Aft er this transcription, the PCR is performed with universal primer complementary to tag sequence, used in reverse transcription and specifi c sequence of particular miRNA.
Another approach uses T4 RNA ligase to attach covalently to 3´ end of miRNA linker adaptor, containing universal primer-binding sequence (Benes and Castoldi 2010) . Using of T4 RNA ligase increases the specifi city and effi ciency of reverse transcription since T4 RNA ligase preferentially modify short ssRNAs.
Another way, how to perform universal reverse transcription, is based on 3´ poly(A) tailing and 5´ ligation of an adaptor sequence. In this way, miRNA is extended on 3´ as well as 5´ end, by a known sequence. Th en, the cDNA is preamplifi ed with use of adapters to increase concentration of all mature miR-NA in the sample. Specifi c miRNA can be measured aft erwards by combination of two primers and probe (commercially provided by Th ermo Fisher).
Real time PCR
Today, the most frequently used technique to measure miRNA expression is the real time PCR. It is known that dynamics of pre-miRNA and mature miRNA diff ers and therefore, in some cases, it may be useful to measure both premature as well as mature miRNAs. To measure the expression of miRNA, precursor PCR primers can be designed on the 3´ and 5´ direction of the hairpin. If desired, a probe can be designed to anneal to loop portion of premature miRNA.
PCR of mature miRNA usually uses a universal tag added during reverse transcription (Figure 2 ). Vendors do not provide information about the sequence of primer used in reverse transcription.
Generally, there are two main strategies how to perform real time PCR of miRNA. Sybr green chemistry uses two primers -one universal and one miR-NA specifi c (Figure 2A ). Another approach relies on labeled probe used together with two unlabeled primers. In this technique, one primer primes adapter added during the reverse transcription and the second one is miRNA specifi c. Probe can be designed to partially align miRNA sequence or anneal to the sequence of adapter added during specifi c reverse transcription ( Figure 2B ) (Chen et al. 2005) .
miRNAs are frequently occurring in isoforms. One way how to discriminate between highly homologues sequences is employment of TaqMan probe (Th ermo Fisher) along with forward and reverse primers that can increase specifi city of PCR product synthesis.
Normalization is always a tricky step in the gene expression analysis. Until the present, no miRNA has been identifi ed with such a stable expression that could be claimed as a versatile normalizer. However, normalization is indispensable and therefore, there are resources recommending some candidates. miR-16 is supposed to be most frequently expressed uniformly. For cell-free circulating miRNA, miR-142-3p, miR-638, RNU44, RNU48, and other have been used. In general, normalizer always has to be checked for the consistency aft er the measurement. When it is not satisfactory, another housekeeper has to be taken. Combination of normalizers can be set as reference. Stability of expression can be tested by several programs (e.g. BestKeeper) or by means of standard statistics. In some cases, samples are spiked with miRNA from another species that is not naturally occurring in the sample or one or combination of synthetic miRNAs. Th ese normalizers are added during the isolation step. It allows normalization at the very last step by measuring concentration of the internal standard (van Rooij 2011; Hrustincova et al. 2015) .
With digital PCR, it is possible to perform absolute quantifi cation of miRNA molecules copies. In this technique, sample aft er amplifi cation is partitioned into 20 000. Droplets containing at least one copy of DNA are detected by fl uorescence and scored as positive and droplets without fl uorescence are scored as negative. Soft ware calculates the concentration of target DNA as copies per microliter from the fraction of positive reactions using Poisson statistics. Normalization is still needed (according MIQE http://www. rdml.org/miqe.php).
Primer design. For experienced users, it may be more convenient to set up their own assay. Th is is accompanied by a need to design primers. Primer design diff ers strongly from that routinely used in standard PCR because of short sequence of miRNA and its similarity to precursors with partially identical sequence. Manual primer design is still employed. Since miRNA specifi c primer is too short for optimization of annealing temperature, a DNA tag added to forward and reverse primer can be used to achieve optimal PCR conditions aft er universal reverse transcription of miRNAs (Balcells et al. 2011) . Spiking of primers by Locked Nucleic Acids to increase annealing temperature has been not recommended by these authors because of lower PCR effi ciency. Soft ware solutions of miRNA primers design are also available (e.g. https://sourceforge.net/projects/mirprimer).
Northern blot
Before real time PCR, assays for miRNA measurement were developed a Northern blotting was widely used to measure miRNA expression. Th e major advantage of this approach was the measurement of primary precursor, precursor, and mature miRNA, on one blot. Sequence of miRNA can be obtained from database (e.g. miRBase) and reverse complementary probe can be ordered without any modifi cation. Forward reaction with T4 polynucleotide kinase can be used for end labeling of the probe. Aft er isolation and gel separation, miRNA is transferred to a membrane, hybridized with probe, and signal is visualized (van Rooij 2011). 
Expression profi ling
Very popular way how to study miRNA is expression profi ling. One approach is built up on the microarray technology (Agilent, Aff ymetrix). Aft er miRNA isolation, T4 RNA ligase is used to attach the labeled nucleotides to the 3´ end of miRNAs. Success of microarray analysis relay on the proper probe design. Since miRNAs sequences are short, probe design has limitations and melting temperature can vary from 45 °C to 74 °C. Chemical modifi cation of nucleotides is used to infl uence the hybridization affi nity of probes and achieve optimal conditions for hybridization of many miRNAs probe duplexes (van Rooij 2011) . Results obtained by microarray profi ling are more useful for comparison of treatments or tissues to visualize changes in spectrum of miRNAs than for quantitative analysis. RNA input for microarray ranges from 100 ng to 1 μg that is one reason why their use has limitations in diagnostics based on biofl uids. In experimental work, array output has to be validated by real time PCR.
Another approach employs real-time PCR profi ling with use of 96 or 384 well plates. Since the number of miRNAs is counted in hundreds, whole spectrum of known miRNAs is possible to cover by this way. Th e PCR-based protocol has higher sensitivity and specifi city compared to microarray one . Real-time PCR profi ler assays are now commercially available at least from two vendors (Qiagen, Th ermo Fisher).
Sequencing
It is also possible to perform a deep sequencing to analyze miRNAs spectrum. Deep sequencing is based on the robust parallel sequencing that provides millions of reads from one sample. An input RNA for deep sequencing using Illumna platform ranges from 500 ng to 5 μg (Burgos et al. 2013) . Sequencing is preceded by generation of small RNA library. During the fi rst step, adapters to 3´ and 5´ end of miRNA are ligated. Double ligated miRNAs are reverse transcribed using RT primer hybridized to the 3´ adapter, and in the next step, PCR amplifi cation is performed. Generation of miRNA library is recently signifi cantly improved and allows attaching of barcode directly to the sequence during PCR step (van Nieuwerburgh et al. 2011) . Consequently, the library is run on a gel, size selected, and sequenced.
Th is technique allows discovery of new miRNAs because it measures absolute abundance of sequences. Since deep sequencing generates a huge volume of data, the number of copies of particular miRNA is determined digitally by free soft ware tools (e.g. miRDeep2, miRanalyzer, SSCprofi ler). A new sequence needs to meet a set of specifi c features to be recognized as miRNA. Newly found mature miRNA has to be long approximately 22nt, genome of interest has to include miRNA sequence, seed sequence should be phylogenetically conserved, and pre-miR-NA sequence has to be able to create a hairpin structure (van Rooij 2011; Hrustincova et al. 2015) .
Interactions between miRNAs and hormones
Giving a rising signifi cance of miRNAs and their involvement in various biological processes, it is not surprising that they have been found to be implicated in development and function of endocrine system. miRNAs appear to play a role in synthesis (Dai et al. 2013; Robertson et al. 2013; Wu et al. 2015) and secretion (Poy et al. 2004; Plaisance et al. 2006 ) of several hormones. Expression of several miRNAs is under hormonal regulation . miRNAs participate in molecular networks related to endocrine system disorders (Imbar and Eisenberg 2014) .
Adrenal gland
Recent studies have reported involvement of some miRNAs in the adrenal gland processes. Th e end product of the renin-angiotensin system -angiotensin II (AngII) up-regulates the expression of miR-21 in human adrenocortical cells (H295R). From more than 200 miRNAs screenings, only miR-21 has been found to be up-regulated by AngII. miR-21 overexpression resulted in an increased aldosterone secretion and proliferation in H295R cells, suggesting that this miRNAs can down-regulate the expression of genes inhibiting the aldosterone secretion and cell proliferation. Authors have also shown that potassium (another secretagogue of aldosterone) had no modifi catory eff ect on miR-21 expression, which makes miR-21 to be a possible specifi c target of AngII (Romero et al. 2008) . Another study has demonstrated post-transcriptional eff ects of miRNA on the gene expression and corticosteroid production (Robertson et al. 2013) . Release of corticosteroids from adrenal cortex is partly accomplished by strictly regulated expression of genes, which encode steroidogenic enzymes catalyzing their biosynthesis. 11-beta-hydroxylase (CYP11B1), responsible for the fi nal conversion producing cortisol and aldosterone synthase (CY-P11B2), plays an equivalent role in the production of aldosterone (Mornet et al. 1989 ). Knockdown of Dicer1 by siRNA in human adrenocortical cell line resulted in a signifi cant increase of CYP11B1 and CY-PAAB2 mRNA. miR-24 has been shown to directly target CYP11B1 and CYP11B2 leading to decrease in aldosterone and cortisol productions. A considerable diff erence in miRNA expression profi les has been observed between normal adrenal tissue and aldosterone producing adenoma; miR-24 being down-regulated in adenoma (Robertson et al. 2013) .
It has been proposed that adrenocorticotropic hormone (ACTH) stimulation may acutely aff ect the adrenal miRNA expression pattern and thereby modulate the adrenal response to acute stressors. miR-96, miR-101a, miR-142-3p, and miR-433 can repress glucocorticoid receptor Nr3c1 by binding to its 3´UTR in mouse adrenal glands (Riester et al. 2012) . Hu et al. (2013) have demonstrated that hormones can regulate miRNAs in the testis, ovary, and adrenal glands steroidogenic cells. Th us, miRNAs may be involved in the posttranscriptional/posttranslational regulation of steroidogenesis. miRNAs, which expression is up-or down-regulated in response to cAMP treatment, was identifi ed in this study using MLTC-1 cells, a model cell line of Leydig cells, and rat granulosa cells. Treatment of cells with cAMP agonist caused an altered expression of several miRNAs: miRNA-212, miRNA-122, miRNA-27a, miR- . Expression level of adrenal miRNAs appears to be regulated by more than one hormone. miRNA expression was studied by profi ling in control rat adrenals and adrenals of rats treated with ACTH, 17-alpha-ethinyl estradiol (17α-E2) or synthetic glucocorticoid dexamethasone (DEX) in order to identify the altered miRNA expression in response to these hormones. Chronic ACTH treatment in vivo altered the levels of many miRNAs, whereas more miRNAs were up-than down-regulated. Signifi cant diff erences have been observed in levels of 163 miRNAs between control adrenals and adrenals from 17α-E2-treated rats. DEX treatment caused changes in miRNA levels in both directions as well .
Ovary
Several recent studies have implicated miRNA role in ovarian development and function. miRNAs are associated with functional regulation of gonadal somatic and granulosa cells. miRNAs expressed in granulosa cells may directly aff ect the expression of specifi c genes, which are involved in the folliculogenesis and ovarian steroidogenesis (Imbar and Eisenberg 2014) . miR-133 is involved in the follicle-stimulating hormone (FSH)-induced estrogen production. Foxl2 (Forkhead L2, a key modulator of steroidogenesis), expressed in ovarian granulosa cells, takes part in the steroidogenesis by regulating genes critical for the estrogen biosynthesis, such as StAR and Cyp19a1. In human and mouse granulosa cells, miR-133 inhibits Foxl2 expression by direct targeting its 3´UTR. Th ereby, it impairs the negative Foxl2-mediated transcriptional regulation of StAR and Cyp19a1 and stimulates the estrogen production (Dai et al. 2013) . It has been shown that cAMP induces miR-132 expression in mouse ovarian granulosa cells. miR-132 induces Cyp19a1 directly by suppressing the expression of an orphan nuclear receptor (Nurr1). Consequently, due to the up-regulation of Cyp19a1, the synthesis of estradiol is induced (Wu et al. 2015) .
According to Yin et al. (2012) , miR-383 promotes the estradiol (E2) release from granulosa cells by direct targeting the RNA binding motif single stranded interacting protein 1.
Testes and epididymis
Numerous miRNAs, abundantly expressed in spermatogenic cells, play a role in the spermatogenesis. Androgens and FSH can act on Sertoli cells and regulate expression of miRNAs involved in the control of the cell adhesion pathways and male fertility (Wang and Xu 2015) . Ma et al. (2013) have suggested that miR-29a may play a vital role in the epididymal development and function owing to a regulatory impact on the androgen signaling pathway and miR-29a. miR-29a expression is repressed by androgen signaling via androgen receptor (AR) in the mouse epididymis and vice versa, miR-29a infl uences AR expression via insulin-like growth factor 1 and p53 regulatory pathways. miR29a over-expression in transgenic mice resulted in epididymis hypoplasia.
Endocrine pancreas
A number of miRNAs play an important role in the islet physiology. Th ey are involved in the regulation of beta-cell function (Poy et al. 2004; Ozcan 2014) . Th ey are implicated in the regulation of glucose homeostasis and can infl uence insulin levels by regulating its production, exocytosis or development of endocrine pancreas. Th ereby, they may be important contributors to establishment of diabetes (Ozcan 2014) . miR-375 has been shown to negatively control the insulin secretion in pancreatic islets by targeting myotrophin. Th e mechanism of secretion modifi ed by miR-375 is independent of changes in glucose metabolism and intracellular Ca 2+ signaling; however, a correlation with direct infl uence on insulin exocytosis has been shown. Other targets of miR-375 may contribute to the regulation of insulin secretion (Poy et al. 2004) . Another study has shown that over-expression of miR-9 inhibits insulin secretion induced by glucose or potassium in INS1E pancreatic beta cells. Results of this study support the idea that adequate miR-9 levels are essential to maintain appropriate levels of granuphilin (which negatively regulates insulin exocytosis) and optimal secretory capacity in insulin-producing cells. Expression of miR-9 target transcription factor Onecut-2 is reduced by the over-expression of miR-9. Silencing of Onecut-2 results in increased granuphilin expression and diminished insulin secretion in response to glucose (Plaisance et al. 2006) .
Th e analysis of miR-7 expression in the fetal and adult human pancreas revealed that miR-7 is predominantly expressed in the endocrine cells of these structures. A coincidence was observed between increased miR-7 expression and a time of rise in hormone encoding genes (insulin, glucagon and somatostatin) during development. miR-7 is supposed to play a role in the endocrine pancreas development and endocrine cell diff erentiation (Correa-Medina et al. 2009 ).
Hypothalamus and pituitary
By using a deep sequencing technique, miRNA expression profi ling of the mouse hypothalamus has been performed. Investigation of miR-24 revealed its function as a regulator of oxytocin synthesis. miR-24 is abundant in hypothalamus and capable of inhibiting oxytocin production by targeting a sequence between the 3´UTR and coding sequence (Choi et al. 2013) . miR-375 is highly expressed in mouse pituitary and specifi cally located in the intermediate lobe. miR-375 is functioning as a mediator of the corticotropin-releasing factor (CRF) signaling pathway. It inhibits proopiomelanocortin (POMC) expression and aff ects the synthesis and secretion of pituitary hormones . It has been proposed that some miRNAs can be implicated in stress-induced suppression of luteinizing hormone (LH) secretion. Stress-induced urocortin 2 (Ucn2) secretion, a member of CRF family, causes increased miR-325-3p expression in rat anterior pituitary cells. Subsequently, miR-325-3p over-expression decreases the intracellular LH levels and suppresses LH beta-subunit translation and secretion (Nemoto et al. 2012) . miRNA seems to be directly involved in the regulation of gonadotropin synthesis by gonadotropinreleasing hormone (GnRH). GnRH stimulation of FSHb (follicle-stimulating hormone, beta polypeptide) expression is dependent on miR-132/212 and involves a Sirtuin1-Forkhead Box O1 pathway. When blocking miR-132/212, total loss of FSH synthesis up-regulation appeared, proposing that this pathway is mandatory for GnRH activation (Lannes et al. 2015) . GnRH induces expression of multiple miRNAs. Gene encoding miR-132 and miR-212 has been shown to be induced by GnRH. Downstream target of miR-132 and miR-212 -p250RhoGAP protein is involved in morphological changes and migration of L-betaT2 cells (immortalized gonadotrope cell line) (Godoy et al. 2011). miRNAs and cell proliferation modulated by hormones miRNAs participate in various endocrine malignancies, such as thyroid malignancies, gastrointestinal neuroendocrine malignancies, adrenocortical carcinomas, and pheochromocytoma (Kentwell et al. 2014) . Wickramasinghe et al. (2009) have reported that E2 inhibits the expression of oncogenic miR-21 in MCF-7 human breast cancer cells. Both alpha and beta estrogen receptors appear to contribute to miR-21 repression by E2. Th e decrease of miR-21 correlates with protein expression of its targets Pdcd4, PTEN and Bcl-2 (Wickramasinghe et al. 2009 ). Eskildsen et al. (2013) have performed an analysis of miRNAs potentially involved in AngII-mediated hypertension in rats and hypertensive patients. miR-132 and miR-212 have been found to be highly increased in the heart, aortic wall, and kidney of rat with hypertension and cardiac hypertrophy following chronic AngII infusion. Th ese miRNAs were also increased by activation of endothelin receptor -G-alpha q coupled receptor. A decrease in expression levels of miR-132 and miR-212 was found in human arteries from by-pass operated patients who were treated with angiotensin receptor type 1 blockers, while beta-blocker treatment did not exhibit any eff ect. Results from this study may suggest that miR-132 and miR-212 could be involved in AngII-induced Gq-signaling pathway leading to hypertension.
Conclusions and perspectives
Research focused on the function and possible medical application of miRNAs is exponentially growing in all biomedical sciences, including endocrinology. Recent review provides a brief overview of recent knowledge about the mammalian non-coding RNA classes, including miRNAs, miRNAs discovery, nomenclature, and synthesis and actually applicable research strategies. miRNAs execute their functions by interference with 3`UTR region of regulated mRNA. It has been shown that there are several targets for one particular miRNA. In silico research in public databases allows to search for possible miRNAs targets in mammalian genomes. miRNA/mRNA interactions must be confi rmed experimentally. Many of them are commercially available tools for miRNA investigation and miRNA/mRNA interactions validation. At present, the role of miRNAs is more frequently investigated under in vitro conditions, using cell proliferation, migration or viability as means to reveal mechanisms of miRNA functioning. Th ese strategies have predominantly been employed in cancer-oriented research. miRNAs are investigated also in a complex system of integrative sciences, but this approach still lacks effi cient techniques to deliver miRNAs into the organism and methods how to study miRNA signaling under in vivo conditions. In spite of the fact that a huge progress has been made in the identifi cation of miRNAs functions in the regulation of several endocrine glands, including, pituitary, pancreas, testes, epididymis, ovary, adrenal gland and the hypothalamus.
